L & S Advisors Inc Merck & Co., Inc. Transaction History

L & S Advisors Inc

$771 Million
Q2 2024

A detailed history of L & S Advisors Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, L & S Advisors Inc holds 41,912 shares of MRK stock, worth $4.35 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares

41,912

Previous 63,343 33.83%

Holding current value

$4.35 Million

Previous $8.36 Million 37.93%

% of portfolio

0.67%

Previous 1.08%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$123.8 - $132.96 $2.65 Million - $2.85 Million	-21,431 Reduced 33.83%	41,912 $5.19 Million
Q1 2024 May 10, 2024	BUY	$113.24 - $131.95 $5.27 Million - $6.15 Million	46,577 Added 277.81%	63,343 $8.36 Million
Q4 2023 Feb 13, 2024	BUY	$100.18 - $109.02 $1,302 - $1,417	13 Added 0.08%	16,766 $1.83 Million
Q3 2023 Nov 13, 2023	SELL	$102.95 - $114.33 $4.64 Million - $5.15 Million	-45,061 Reduced 72.9%	16,753 $1.72 Million
Q2 2023 Aug 11, 2023	SELL	$108.61 - $118.38 $151,076 - $164,666	-1,391 Reduced 2.2%	61,814 $7.13 Million
Q1 2023 May 10, 2023	SELL	$102.94 - $114.86 $5.6 Million - $6.24 Million	-54,358 Reduced 46.24%	63,205 $6.72 Million
Q4 2022 Feb 13, 2023	BUY	$87.44 - $112.11 $4.58 Million - $5.87 Million	52,352 Added 80.28%	117,563 $13 Million
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $728,479 - $818,365	-8,618 Reduced 11.67%	65,211 $5.62 Million
Q2 2022 Aug 12, 2022	BUY	$83.49 - $94.64 $2.52 Million - $2.86 Million	30,217 Added 69.29%	73,829 $6.73 Million
Q1 2022 May 11, 2022	SELL	$73.51 - $82.4 $53,662 - $60,152	-730 Reduced 1.65%	43,612 $3.58 Million
Q4 2021 Feb 09, 2022	SELL	$72.28 - $90.54 $1.45 Million - $1.82 Million	-20,058 Reduced 31.15%	44,342 $3.4 Million
Q3 2021 Nov 09, 2021	BUY	$71.68 - $78.83 $1.43 Million - $1.57 Million	19,905 Added 44.74%	64,400 $4.84 Million
Q2 2021 Aug 12, 2021	SELL	$70.31 - $77.77 $6,679 - $7,388	-95 Reduced 0.21%	44,495 $3.46 Million
Q1 2021 May 10, 2021	SELL	$68.86 - $81.11 $1.15 Million - $1.36 Million	-16,761 Reduced 27.32%	44,590 $3.44 Million
Q4 2020 Feb 16, 2021	SELL	$71.77 - $79.65 $5.3 Million - $5.88 Million	-73,878 Reduced 54.63%	61,351 $5.02 Million
Q3 2020 Nov 13, 2020	BUY	$73.18 - $82.95 $2.21 Million - $2.5 Million	30,157 Added 28.7%	135,229 $11.2 Million
Q2 2020 Aug 13, 2020	SELL	$70.42 - $80.13 $2.28 Million - $2.59 Million	-32,331 Reduced 23.53%	105,072 $8.13 Million
Q1 2020 May 13, 2020	SELL	$63.36 - $87.82 $2.05 Million - $2.84 Million	-32,303 Reduced 19.03%	137,403 $10.6 Million
Q4 2019 Feb 13, 2020	BUY	$77.58 - $87.54 $1.48 Million - $1.67 Million	19,078 Added 12.67%	169,706 $15.4 Million
Q3 2019 Nov 14, 2019	BUY	$76.08 - $82.93 $1.14 Million - $1.25 Million	15,018 Added 11.07%	150,628 $12.7 Million
Q2 2019 Aug 13, 2019	SELL	$69.84 - $81.59 $1.2 Million - $1.4 Million	-17,170 Reduced 11.24%	135,610 $11.4 Million
Q1 2019 May 14, 2019	SELL	$69.58 - $79.36 $281,868 - $321,487	-4,051 Reduced 2.58%	152,780 $12.7 Million
Q4 2018 Feb 14, 2019	BUY	$65.24 - $75.71 $124,999 - $145,060	1,916 Added 1.24%	156,831 $12 Million
Q3 2018 Nov 14, 2018	BUY	$57.69 - $67.84 $5.42 Million - $6.38 Million	94,017 Added 154.38%	154,915 $11 Million
Q2 2018 Aug 13, 2018	BUY	$50.83 - $59.72 $71,111 - $83,548	1,399 Added 2.35%	60,898 $3.7 Million
Q1 2018 May 14, 2018	BUY	$50.96 - $59.23 $969,310 - $1.13 Million	19,021 Added 46.99%	59,499 $3.24 Million
Q4 2017 Feb 14, 2018	SELL	$51.62 - $61.64 $238,277 - $284,530	-4,616 Reduced 10.24%	40,478 $2.28 Million
Q3 2017 Nov 14, 2017	SELL	$58.67 - $63.13 $4,869 - $5,239	-83 Reduced 0.18%	45,094 $2.89 Million
Q2 2017 Aug 14, 2017	BUY	N/A	45,177	45,177 $2.9 Million

Others Institutions Holding MRK

# of Institutions

3,805

Shares Held

1.92B

Call Options Held

13.4M

Put Options Held

10.6M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $263B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of L & S Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on L & S Advisors Inc with notifications on news.

Account